百潤股份(002568.SZ):強爽系列產品的快速增長是預調雞尾酒市場發展的必然趨勢
格隆匯6月9日丨百潤股份(002568.SZ)於2023年6月8日接受機構調研,交流環節中,就“公司強爽系列產品銷售情況快速增長的原因是什麼?”,公司回覆稱,強爽系列產品於2016年推出後,經歷多輪包裝升級與口味升級,產品力不斷提升。經成熟市場驗證,酒精度為8度至9度的產品是預調雞尾酒市場最暢銷的系列,公司精準定位持續營銷推廣,到2022年下半年,強爽系列在話題營銷、聯名營銷、熱播劇植入等共同推動下,銷量實現強勁增長。強爽系列產品的快速增長是預調雞尾酒市場發展的必然趨勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.